- Patients and Families
- About Alpha-1
- Testing for Alpha-1
- ARALAST Therapy
- Insurance Assistance
- Help and Support
Managing Alpha-1 from diagnosis through daily living
Events
| Regional Support Group Meeting Boise, ID |
October 4, 2008 |
| Alpha-1 Education Day Pittsburgh, PA |
October 18, 2008 |
To learn about events of interest to healthcare professionals, visit Conferences.
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
 |
To view PDF, you will need Adobe® Acrobat® Reader® software. |
- Patients & Families
- Healthcare Professionals
- Site Map
- Privacy Policy
- Terms & Conditions
- About Baxter BioScience
Copyright © 2006-2008. Baxter Healthcare Corporation. All rights reserved.
Site Last Updated 10/02/08